Annual Operating Profit
-$515.29 M
-$57.13 M-12.47%
31 December 2023
Summary:
Intellia Therapeutics annual operaing income is currently -$515.29 million, with the most recent change of -$57.13 million (-12.47%) on 31 December 2023. During the last 3 years, it has fallen by -$247.44 million (-92.38%). NTLA annual operating profit is now -3742.87% below its all-time high of -$13.41 million, reached on 31 December 2015.NTLA Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$144.77 M
-$5.73 M-4.12%
30 September 2024
Summary:
Intellia Therapeutics quarterly operating income is currently -$144.77 million, with the most recent change of -$5.73 million (-4.12%) on 30 September 2024. Over the past year, it has dropped by -$4.88 million (-3.49%). NTLA quarterly operating profit is now -12014.64% below its all-time high of -$1.20 million, reached on 31 March 2015.NTLA Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$537.71 M
-$13.66 M-2.61%
30 September 2024
Summary:
Intellia Therapeutics TTM operating income is currently -$537.71 million, with the most recent change of -$13.66 million (-2.61%) on 30 September 2024. Over the past year, it has dropped by -$22.42 million (-4.35%). NTLA TTM operating profit is now -44896.49% below its all-time high of -$1.20 million, reached on 31 March 2015.NTLA TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NTLA Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -3.5% | -4.3% |
| 3 y3 years | -92.4% | -80.0% | -100.8% |
| 5 y5 years | -384.4% | -386.3% | -405.5% |
NTLA Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -92.4% | at low | -80.0% | at low | -100.8% | at low |
| 5 y | 5 years | -384.4% | at low | -415.2% | at low | -405.5% | at low |
| alltime | all time | -3742.9% | at low | <-9999.0% | at low | <-9999.0% | at low |
Intellia Therapeutics Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$144.77 M(+4.1%) | -$537.71 M(+2.6%) |
| June 2024 | - | -$139.04 M(+22.0%) | -$524.04 M(+1.3%) |
| Mar 2024 | - | -$114.00 M(-18.5%) | -$517.34 M(+0.4%) |
| Dec 2023 | -$515.29 M(+12.5%) | -$139.89 M(+6.7%) | -$515.29 M(+6.1%) |
| Sept 2023 | - | -$131.11 M(-0.9%) | -$485.49 M(+5.6%) |
| June 2023 | - | -$132.33 M(+18.2%) | -$459.91 M(+8.0%) |
| Mar 2023 | - | -$111.96 M(+1.7%) | -$425.88 M(-7.0%) |
| Dec 2022 | -$458.16 M(+71.1%) | -$110.09 M(+4.3%) | -$458.16 M(+6.9%) |
| Sept 2022 | - | -$105.53 M(+7.4%) | -$428.49 M(+8.5%) |
| June 2022 | - | -$98.30 M(-31.9%) | -$394.95 M(+8.0%) |
| Mar 2022 | - | -$144.25 M(+79.4%) | -$365.67 M(+36.5%) |
| Dec 2021 | -$267.85 M(+96.1%) | -$80.42 M(+11.7%) | -$267.85 M(+16.5%) |
| Sept 2021 | - | -$71.99 M(+4.3%) | -$229.83 M(+23.6%) |
| June 2021 | - | -$69.02 M(+48.7%) | -$185.94 M(+24.0%) |
| Mar 2021 | - | -$46.42 M(+9.5%) | -$149.96 M(+9.8%) |
| Dec 2020 | -$136.58 M(+28.4%) | -$42.40 M(+50.9%) | -$136.58 M(+10.2%) |
| Sept 2020 | - | -$28.10 M(-14.9%) | -$123.95 M(+2.3%) |
| June 2020 | - | -$33.03 M(-0.0%) | -$121.18 M(+4.8%) |
| Mar 2020 | - | -$33.05 M(+11.0%) | -$115.61 M(+8.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | -$106.37 M(+17.1%) | -$29.77 M(+17.5%) | -$106.37 M(+9.3%) |
| Sept 2019 | - | -$25.33 M(-7.8%) | -$97.34 M(+1.3%) |
| June 2019 | - | -$27.46 M(+15.3%) | -$96.11 M(+4.2%) |
| Mar 2019 | - | -$23.81 M(+14.8%) | -$92.25 M(+1.5%) |
| Dec 2018 | -$90.87 M(+30.6%) | -$20.75 M(-13.9%) | -$90.87 M(-4.2%) |
| Sept 2018 | - | -$24.10 M(+2.1%) | -$94.84 M(+9.5%) |
| June 2018 | - | -$23.59 M(+5.2%) | -$86.61 M(+9.6%) |
| Mar 2018 | - | -$22.43 M(-9.2%) | -$79.04 M(+13.6%) |
| Dec 2017 | -$69.56 M(+116.3%) | -$24.71 M(+55.7%) | -$69.56 M(+25.0%) |
| Sept 2017 | - | -$15.88 M(-0.9%) | -$55.66 M(+17.2%) |
| June 2017 | - | -$16.02 M(+23.7%) | -$47.48 M(+23.6%) |
| Mar 2017 | - | -$12.95 M(+19.6%) | -$38.41 M(+19.4%) |
| Dec 2016 | -$32.16 M(+139.8%) | -$10.82 M(+40.6%) | -$32.16 M(+19.9%) |
| Sept 2016 | - | -$7.70 M(+10.8%) | -$26.83 M(+19.6%) |
| June 2016 | - | -$6.95 M(+3.8%) | -$22.43 M(+18.6%) |
| Mar 2016 | - | -$6.69 M(+21.9%) | -$18.91 M(+41.0%) |
| Dec 2015 | -$13.41 M | -$5.49 M(+66.3%) | -$13.41 M(+69.3%) |
| Sept 2015 | - | -$3.30 M(-3.5%) | -$7.92 M(+71.5%) |
| June 2015 | - | -$3.42 M(+186.4%) | -$4.62 M(+286.4%) |
| Mar 2015 | - | -$1.20 M | -$1.20 M |
FAQ
- What is Intellia Therapeutics annual operaing income?
- What is the all time high annual operating profit for Intellia Therapeutics?
- What is Intellia Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for Intellia Therapeutics?
- What is Intellia Therapeutics quarterly operating profit year-on-year change?
- What is Intellia Therapeutics TTM operating income?
- What is the all time high TTM operating profit for Intellia Therapeutics?
- What is Intellia Therapeutics TTM operating profit year-on-year change?
What is Intellia Therapeutics annual operaing income?
The current annual operating profit of NTLA is -$515.29 M
What is the all time high annual operating profit for Intellia Therapeutics?
Intellia Therapeutics all-time high annual operaing income is -$13.41 M
What is Intellia Therapeutics quarterly operating income?
The current quarterly operating profit of NTLA is -$144.77 M
What is the all time high quarterly operating profit for Intellia Therapeutics?
Intellia Therapeutics all-time high quarterly operating income is -$1.20 M
What is Intellia Therapeutics quarterly operating profit year-on-year change?
Over the past year, NTLA quarterly operating income has changed by -$4.88 M (-3.49%)
What is Intellia Therapeutics TTM operating income?
The current TTM operating profit of NTLA is -$537.71 M
What is the all time high TTM operating profit for Intellia Therapeutics?
Intellia Therapeutics all-time high TTM operating income is -$1.20 M
What is Intellia Therapeutics TTM operating profit year-on-year change?
Over the past year, NTLA TTM operating income has changed by -$22.42 M (-4.35%)